Drug shows promise for diabetic retinopathy patients

Washington, Apr 28 (ANI): A drug that was developed to combat age-related macular degeneration (AMD) could be beneficial for people with a common form of diabetic retinopathy, according to a study.

According to the Diabetic Retinopathy Clinical Research (DRCR) Network study, treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone.

DME is the main cause of vision loss in people with diabetes mellitus.

After one-year follow-up, the researchers found that nearly 50pct of study patients who received the new combined treatment had substantial improvement in vision, compared with 28pct who received laser treatment alone.

http://news.oneindia.in/2010/04/28/blindingdisease-drug-shows-promise-for-diabeticretinop.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: